Semaglutide
A GLP-1 receptor agonist that improves glycemic control and reduces appetite.
FDA-approved·Regulatory status as of May 2026
Relevance for women
FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic); widely prescribed via telehealth.
Providers that offer Semaglutide
- 4.5/5
Evergreen Women's Health
Strongest fit for perimenopausal women seeking continuity of care — pairs hormone testing with peptide protocols.
- 4.0/5
Canopy Telehealth Clinic
Broad catalog and broad geographic reach; longer intake process but thorough lab work.
See the full provider comparison for all peptides side by side.